Dehydrogenase Inhibitor

Dehydrogenase inhibitors are compounds that impede the activity of dehydrogenase enzymes, which are responsible for catalyzing the oxidation-reduction reactions in various metabolic pathways. By inhibiting these enzymes, these compounds can disrupt the conversion of substrates into products, affecting cellular energy production and metabolism. This inhibition can lead to decreased production of ATP, the primary energy currency of the cell, and accumulation of metabolic intermediates, potentially leading to altered cellular functions or cell death. Dehydrogenase inhibitors are utilized in the treatment of various conditions, such as diabetes (e.g., glyceraldehyde 3-phosphate dehydrogenase inhibitors) and cancer (e.g., isocitrate dehydrogenase inhibitors), where they can help modulate metabolic pathways that are dysregulated in these diseases.